Hyperimmune plasma infusion in an immunocompromised Covid-19 patient previously treated for follicular lymphoma
{{output}}
Covid-19 in immunocompromised patients shows a prolonged course and may lead to a poor prognosis. Although data on hyperimmune plasma for treatment of Covid-19 suggest an improved outcome in immunocompetent patients, limited data are currently available in imm... ...
